ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

FLGT Fulgent Genetics Inc

21.50
0.26 (1.22%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Fulgent Genetics Inc NASDAQ:FLGT NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.26 1.22% 21.50 19.51 30.00 21.60 20.50 20.50 355,667 05:00:01

FLGT SHAREHOLDER ALERT: Jakubowitz Law Reminds Fulgent Shareholders of a Lead Plaintiff Deadline of November 21, 2022

30/09/2022 10:45am

PR Newswire (US)


Fulgent Genetics (NASDAQ:FLGT)
Historical Stock Chart


From May 2022 to May 2024

Click Here for more Fulgent Genetics Charts.

NEW YORK, Sept. 30, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Fulgent Genetics, Inc. (NASDAQ: FLGT).

To receive updates on the lawsuit, fill out the form:
https://claimyourloss.com/securities/fulgent-genetics-inc-loss-submission-form/?id=32241&from=4

The lawsuit seeks to recover losses for shareholders who purchased Fulgent between March 22, 2019 andĀ August 4, 2022.

Shareholders interested in acting as a lead plaintiff representing the class of wronged shareholders have until November 21, 2022 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

According to a filed complaint, Fulgent Genetics, Inc. issued materially false and/or misleading statements and/or failed to disclose that: (i) Fulgent had been conducting medically unnecessary laboratory testing, engaging in improper billing practices in relation to laboratory testing, and providing or receiving remuneration in violation of the Anti-Kickback Statute and Stark Law; (ii) accordingly, Fulgent was likely to become subject to enhanced legal and regulatory scrutiny; (iii) Fulgent's revenues, to the extent they were derived from the foregoing unlawful conduct, were unsustainable; (iv) the foregoing, once revealed, was likely to subject the Company to significant financial and/or reputational harm; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

Cision View original content:https://www.prnewswire.com/news-releases/flgt-shareholder-alert-jakubowitz-law-reminds-fulgent-shareholders-of-a-lead-plaintiff-deadline-of-november-21-2022-301637293.html

SOURCE Jakubowitz Law

Copyright 2022 PR Newswire

1 Year Fulgent Genetics Chart

1 Year Fulgent Genetics Chart

1 Month Fulgent Genetics Chart

1 Month Fulgent Genetics Chart

Your Recent History

Delayed Upgrade Clock